MARKET

CUBT

CUBT

Curative Biotechnology Inc
OTCID
0.0070
0.0000
0.00%
Closed 11:00 12/18 EST
OPEN
0.0070
PREV CLOSE
0.0070
HIGH
0.0070
LOW
0.0070
VOLUME
396.24K
TURNOVER
2.77K
52 WEEK HIGH
0.029
52 WEEK LOW
0.0034
MARKET CAP
7.51M
P/E (TTM)
-0.6604
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CUBT last week (1208-1212)?
Weekly Report · 3d ago
Weekly Report: what happened at CUBT last week (1201-1205)?
Weekly Report · 12/08 09:34
Weekly Report: what happened at CUBT last week (1124-1128)?
Weekly Report · 12/01 09:32
Weekly Report: what happened at CUBT last week (1117-1121)?
Weekly Report · 11/24 09:34
Curative Biotech withdraws S-1, approves revised 150-to-1 reverse split
TipRanks · 11/18 14:55
Curative Biotechnology, Inc. Announces Letter to Shareholders
Barchart · 11/18 07:15
Weekly Report: what happened at CUBT last week (1110-1114)?
Weekly Report · 11/17 09:35
Weekly Report: what happened at CUBT last week (1103-1107)?
Weekly Report · 11/10 09:34
More
About CUBT
Curative Biotechnology, Inc. is a development stage biomedical company focused on therapies for rare diseases. The Company is identifying, acquiring, and developing disease modifying therapeutic drug candidates with a concentration on rare disease indications. It has ongoing programs in three different therapeutic areas: degenerative eye disease, infectious disease, and neuro-oncology. It is primarily focused on its degenerative eye disease platform. The first therapeutic to be developed on this platform is a Metformin Reformulation targeting the treatment of intermediate and late-stage age-related macular degeneration (AMD) disease. Its development pipeline is focused on three therapeutic areas: degenerative eye disease, infectious disease, and neuro oncology. IMT504 is an oligodeoxynucleotide (ODN). ODNs are synthetic molecules that stimulate different kinds of cells of immune system of animals and humans.

Webull offers Curative Biotechnology Inc stock information, including OTCID: CUBT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CUBT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CUBT stock methods without spending real money on the virtual paper trading platform.